Pharmacologic treatment of kidney stones: Current medication and pH monitoring.
Calcium oxalate
Cistina
Cystine
Estruvita
Manejo farmacológico
Manejo médico
Medical management
Monitorización del pH
Nefrolitiasis
Nephrolithiasis
Oxalato cálcico
Pharmacological management
Struvite
Uric acid
pH monitoring
Ácido úrico
Journal
Actas urologicas espanolas
ISSN: 2173-5786
Titre abrégé: Actas Urol Esp (Engl Ed)
Pays: Spain
ID NLM: 101771154
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
received:
16
10
2023
accepted:
20
11
2023
pubmed:
4
12
2023
medline:
4
12
2023
entrez:
3
12
2023
Statut:
aheadofprint
Résumé
Nephrolithiasis is a globally prevalent urologic condition associated with significant morbidity and patient discomfort. Current management of kidney stones includes both surgical and pharmacologic interventions. Though surgery may be necessary under certain circumstances, pharmacologic treatment is a more affordable, readily available, and a less invasive option for patients. A comprehensive scoping review was conducted to summarize the available literature on the pharmacologic strategies for managing the predominant stone types including calcium oxalate, calcium phosphate, uric acid, struvite, and cystine stones. Central to these therapeutic approaches is the regulation of factors such as urine pH, stone crystallization, and patient metabolics that precipitate stone development and growth. This review highlights the pharmacological options available for treating each kidney stone type, emphasizing the importance of patient tailored medical management that should be considered by every physician.
Identifiants
pubmed: 38043680
pii: S2173-5786(23)00136-1
doi: 10.1016/j.acuroe.2023.11.008
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
spa
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 The Author(s). Published by Elsevier España, S.L.U. All rights reserved.